Developer of computational drug discovery platform. It offers an AI-based single-cell immune monitoring platform for biomarker endpoints, comprehensive discovery, and annotation of cellular phenotypes. It enhances drug discovery for oncology, autoimmunity, and infectious diseases.
← All startups
Ozette
Series ADeveloper of computational drug discovery platform. It offers an AI-based single-cell immune monitoring platform for biomarker endpoints, comprehensive discovery, and annotation of cellular phenotypes.
About
Institutional investors
M12Cercano ManagementMadronaOCV PartnersDuke UniversityAlexandriaVulcanAllen Institute for Artificial Intelligence
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ See who's investing in HealthTech — full fund directory with check size and geography.